• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经治疗的高血压患者的心肌缺血:单次小剂量口服β-肾上腺素能阻滞剂的作用。

Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent.

作者信息

Stone J G, Foëx P, Sear J W, Johnson L L, Khambatta H J, Triner L

机构信息

Department of Anesthesiology, Columbia University, College of Physicians and Surgeons, New York, New York 10032.

出版信息

Anesthesiology. 1988 Apr;68(4):495-500.

PMID:2895596
Abstract

In a non-double-blind, prospective, randomized study, the intra-operative electrocardiograms of 128 mildly hypertensive surgical patients were examined in order to determine the incidence of myocardial ischemia during anesthesia. No patient had been receiving chronic antihypertensive therapy prior to the study, but a single small oral dose of a beta-adrenergic blocking agent (labetalol, atenolol, or oxprenolol) was given to 89 of them along with premedication. Forty-four per cent of the untreated control patients and 61% of the patients pretreated with a beta-adrenergic blocking agent had normal preoperative electrocardiograms and no risk factors for coronary artery disease other than hypertension (this difference between groups was not statistically significant). During tracheal intubation and/or emergence from anesthesia, a brief, self-limited episode of myocardial ischemia was detected in 11 of 39 untreated control patients, and in two of 89 patients pretreated with a beta-adrenergic blocking agent (P less than 0.001). Tachycardia always accompanied the ischemic events, but a conspicuous increase in blood pressure did not. The authors conclude that mild hypertension, when untreated prior to the induction of anesthesia, is associated with a high incidence of myocardial ischemia; and that a single small oral dose of a beta-adrenergic blocking agent, given with pre-medication, can significantly reduce that risk.

摘要

在一项非双盲、前瞻性、随机研究中,对128例轻度高血压手术患者的术中心电图进行了检查,以确定麻醉期间心肌缺血的发生率。在研究之前,没有患者接受过慢性抗高血压治疗,但其中89例患者在术前用药时服用了单次小剂量口服β-肾上腺素能阻滞剂(拉贝洛尔、阿替洛尔或氧烯洛尔)。44%的未治疗对照患者和61%接受β-肾上腺素能阻滞剂预处理的患者术前心电图正常,除高血压外无冠状动脉疾病危险因素(两组间差异无统计学意义)。在气管插管和/或麻醉苏醒期间,39例未治疗对照患者中有11例以及89例接受β-肾上腺素能阻滞剂预处理的患者中有2例检测到短暂的、自限性心肌缺血发作(P<0.001)。心动过速总是伴随缺血事件,但血压没有明显升高。作者得出结论,麻醉诱导前未治疗的轻度高血压与心肌缺血的高发生率相关;术前用药时服用单次小剂量口服β-肾上腺素能阻滞剂可显著降低该风险。

相似文献

1
Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent.未经治疗的高血压患者的心肌缺血:单次小剂量口服β-肾上腺素能阻滞剂的作用。
Anesthesiology. 1988 Apr;68(4):495-500.
2
Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.心得平用于心肌梗死幸存者:结合其他β受体阻滞剂心肌梗死后试验对欧洲梗死研究结果的简要综述。
Z Kardiol. 1985;74 Suppl 6:165-72.
3
[Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].[β受体阻滞剂长期口服治疗对体外循环后冠心病患者使用肾上腺素进行正性肌力治疗是否有影响?]
Herz. 1995 Dec;20(6):399-411.
4
Current status of labetalol, the first alpha- and beta-blocking agent.拉贝洛尔(第一种α和β受体阻滞剂)的现状
Int J Clin Pharmacol Ther Toxicol. 1985 Nov;23(11):617-28.
5
Perioperative sympatholysis. Beneficial effects of the alpha 2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. McSPI--Europe Research Group.围手术期交感神经阻滞。α2肾上腺素能受体激动剂米伐折醇对血流动力学稳定性和心肌缺血的有益作用。欧洲McSPI研究小组。
Anesthesiology. 1997 Feb;86(2):346-63.
6
[Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].[α1和β1 - 2受体阻滞剂(拉贝洛尔)与β1受体阻滞剂(阿替洛尔)对高血压患者的比较效应]
J Pharmacol. 1983;14 Suppl 2:121-9.
7
Labetalol in the treatment of angina pectoris.拉贝洛尔治疗心绞痛。
Int J Clin Pharmacol Ther Toxicol. 1987 Mar;25(3):166-74.
8
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.在降低既往心肌梗死患者心血管事件方面,基于维拉帕米缓释片的治疗策略等同于基于阿替洛尔的治疗策略:一项国际维拉帕米缓释片-群多普利(INVEST)子研究。
Am Heart J. 2008 Aug;156(2):241-7. doi: 10.1016/j.ahj.2008.02.023.
9
Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement.马凡综合征患者的β受体阻滞剂治疗与全主动脉置换术
Eur J Cardiothorac Surg. 2004 Nov;26(5):901-6. doi: 10.1016/j.ejcts.2004.07.010.
10
[Do beta-blockers prevent coronary events in hypertensive patients?].[β受体阻滞剂能否预防高血压患者发生冠状动脉事件?]
Arch Mal Coeur Vaiss. 2005 Sep;98(9):881-8.

引用本文的文献

1
Generalisability of randomised trials evaluating perioperative β-blocker therapy in noncardiac surgery.评估非心脏手术围手术期β受体阻滞剂治疗的随机试验的可推广性。
Br J Anaesth. 2020 Dec;125(6):926-934. doi: 10.1016/j.bja.2020.08.006. Epub 2020 Sep 2.
2
Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery.围手术期使用β受体阻滞剂预防非心脏手术成年患者的手术相关死亡率和发病率。
Cochrane Database Syst Rev. 2019 Sep 26;9(9):CD013438. doi: 10.1002/14651858.CD013438.
3
Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
围手术期使用β受体阻滞剂预防手术相关的死亡率和发病率。
Cochrane Database Syst Rev. 2018 Mar 13;3(3):CD004476. doi: 10.1002/14651858.CD004476.pub3.
4
New-onset atrial fibrillation: an update.新发心房颤动:最新进展
J Anesth. 2018 Jun;32(3):414-424. doi: 10.1007/s00540-018-2478-8. Epub 2018 Mar 9.
5
Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery.用于降低血管手术患者围手术期心脏风险的β-肾上腺素能阻滞剂。
Cochrane Database Syst Rev. 2015 Jan 14;1(1):CD006342. doi: 10.1002/14651858.CD006342.pub2.
6
Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation.预防与气管插管血流动力学反应相关发病的药理制剂。
Cochrane Database Syst Rev. 2013 Jul 3;2013(7):CD004087. doi: 10.1002/14651858.CD004087.pub2.
7
Management of postoperative atrial fibrillation.术后心房颤动的管理。
J Anesth. 2012 Jun;26(3):429-37. doi: 10.1007/s00540-012-1330-9. Epub 2012 Jan 25.
8
Perioperative control of hypertension: when will it adversely affect perioperative outcome?围手术期高血压的控制:何时会对围手术期结局产生不利影响?
Curr Hypertens Rep. 2008 Dec;10(6):480-7. doi: 10.1007/s11906-008-0090-2.
9
[Perioperative pharmacological myocardial protection. Systematic literature-based process optimization].[围手术期药理学心肌保护。基于系统文献的流程优化]
Anaesthesist. 2008 Jul;57(7):655-69. doi: 10.1007/s00101-008-1396-9.
10
Clinical role and efficacy of landiolol in the intensive care unit.兰地洛尔在重症监护病房的临床作用及疗效
J Anesth. 2008;22(1):64-9. doi: 10.1007/s00540-007-0573-3. Epub 2008 Feb 27.